Although research on liver injury and ferroptosis has shown promising results, it is mainly at the level of animal models, and there is a long way to go before clinical translation
Sweeney MD, Sagare AP, Zlokovic BV
However, the complexity of human brain injury and the limitations of animal models in predicting human neurological outcomes require extensive clinical validation before considering these applications
Interestingly, GLP-1 receptor agonists oppose sympathetic effects on cardiac ventricular excitability, reducing ventricular arrhythmic risk through stimulation of cardiac parasympathetic neurons
Cathelicidin LL-37 is an antimicrobial peptide found naturally in human immune cells
Large-scale, randomized controlled trials are critically needed to establish definitive efficacy for specific clinical indications and to compare these peptides with established therapies